Salvage therapy for hepatocellular carcinoma with thalidomide

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

270

HTML

2438

Tables (1-6)

236

Sum=2944

Mar 1, 2004 (publication date) through Feb 18, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Mar 1, 2004; 10(5): 649-653
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.649

Table 4 Hepatocellular carcinoma stage and survival time, Okuda stage and survival time

MSD: medium survival day.

Citation: Wang TE, Kao CR, Lin SC, Chang WH, Chu CH, Lin J, Hsieh RK. Salvage therapy for hepatocellular carcinoma with thalidomide. World J Gastroenterol 2004; 10(5): 649-653
URL: https://www.wjgnet.com/1007-9327/full/v10/i5/649.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i5.649